Since we previously determined that both TRAF2 and STAT3 are suppressed by miR-671-5p to affect tumor migration, CSC ability and radioresistance in GBM, we attempted to identify the clinical connection between TRAF2 and STAT3 expression and disease progression. This evidence concerns the gene STAT3 and glioblastoma.